https://orcid.org/0000-0002-3631-9852
References
- Morton CA, Szeimies RM, Basset-Seguin N, et al. European Dermatology Forum Guidelines on topical photodynamic therapy 2019 part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas. J Eur Acad Dermatol Venereol. 2019;33(12):2225–2238.
- Gholam P, Kroehl V, Enk AH. Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. Dermatology. 2013;226(3):253–259.
- Borroni RG, Carugno A, Rivetti N, et al. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer. Photodermatol Photoimmunol Photomed. 2013;29(2):73–77.
- Gholam P, Denk K, Sehr T, et al. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol. 2010;63(2):213–218.
- Ang JM, Riaz IB, Kamal MU, et al. Photodynamic therapy and pain: a systematic review. Photodiagn Photodyn Ther. 2017;19:308–344.
- Wiegell SR, Skiveren J, Philipsen PA, et al. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158(4):727–733.
- Apalla Z, Sotiriou E, Panagiotidou D, et al. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy. Photodermatol Photoimmunol Photomed. 2011;27(4):181–185.
- Gholam P, Weberschock T, Denk K, et al. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology. 2011;222(4):358–362.
- Fink C, Enk A, Gholam P. Photodynamic therapy–aspects of pain management. J Dtsch Dermatol Ges. 2015;13(1):15–22.
- Keller A, Hartmann J, Enk A, et al. Pulse rate and blood pressure changes during low-irradiance PDT compared with conventional PDT in the treatment of facial actinic keratoses: a retrospective study. Photodermatol Photoimmunol Photomed. 2021.
- Morton CA, Braathen LR. Daylight photodynamic therapy for actinic keratoses. Am J Clin Dermatol. 2018;19(5):647–656.
- Wiegell SR, Haedersdal M, Philipsen PA, et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol. 2008;158(4):740–746.
- Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol. 2015;29(12):2342–2348.
- Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol. 2014;171(5):1164–1171.
- Wiegell SR, Fabricius S, Heydenreich J, et al. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol. 2013;168(1):186–191.
- Grinblat B, Galimberti G, Pantoja G, et al. Feasibility of daylight-mediated photodynamic therapy for actinic keratosis throughout the year in Central and South America: a meteorological study. Int J Dermatol. 2016;55(9):e488–e493.
- Spelman L, Rubel D, Murrell DF, et al. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: evidence from a clinical and meteorological study. Aust J Dermatol. 2016;57(1):24–28.
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–3104.
- Boonstra AM, Stewart RE, Koke AJ, et al. Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: variability and influence of sex and catastrophizing. Front Psychol. 2016;7:1466.
- Willenbrink TJ, Ruiz ES, Cornejo CM, et al. Field cancerization: definition, epidemiology, risk factors, and outcomes. J Am Acad Dermatol. 2020;83(3):709–717.